Nuzenio

Endpoints News Endpoints

Endpoints News Endpoints entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 24 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Is China’s work ethic a ‘wake-up call’?; The megamerger that wasn’t; and more - Endpoints NewsEndpoints News · Sat, 08 Aug 2026 10:00:00 GMTFDA to hold adcomm for Grail cancer test that failed in large, randomized trial - Endpoints NewsEndpoints News · Fri, 07 Aug 2026 16:08:00 GMTBioMarin discontinues rare disease drug; CSL and Arcturus split up - Endpoints NewsEndpoints News · Fri, 07 Aug 2026 15:08:00 GMTJennifer Taubert announces retirement from J&J; Takeda’s global TYK2 leader exits - Endpoints NewsEndpoints News · Fri, 07 Aug 2026 11:00:00 GMTReplimune melanoma drug snags coveted FDA approval after yearlong clash, two rejections - Endpoints NewsEndpoints News · Thu, 06 Aug 2026 20:03:00 GMTExclusive: FDA outlines expedited IND pilot plans, seeking to pick up to 10 programs by year's end - Endpoints NewsEndpoints News · Thu, 06 Aug 2026 19:17:43 GMTSarepta pushes back Elevidys timeline; Emergent lays off 90 staffers - Endpoints NewsEndpoints News · Thu, 06 Aug 2026 13:55:00 GMTTarsus bets $450M on Alkeus’ Stargardt drug - Endpoints NewsEndpoints News · Thu, 06 Aug 2026 12:57:00 GMT

Timeline

Sat, 08 Aug 2026 10:00:00 GMTIs China’s work ethic a ‘wake-up call’?; The megamerger that wasn’t; and more - Endpoints News
Fri, 07 Aug 2026 16:08:00 GMTFDA to hold adcomm for Grail cancer test that failed in large, randomized trial - Endpoints News
Fri, 07 Aug 2026 15:08:00 GMTBioMarin discontinues rare disease drug; CSL and Arcturus split up - Endpoints News
Fri, 07 Aug 2026 11:00:00 GMTJennifer Taubert announces retirement from J&J; Takeda’s global TYK2 leader exits - Endpoints News
Thu, 06 Aug 2026 20:03:00 GMTReplimune melanoma drug snags coveted FDA approval after yearlong clash, two rejections - Endpoints News
Thu, 06 Aug 2026 19:17:43 GMTExclusive: FDA outlines expedited IND pilot plans, seeking to pick up to 10 programs by year's end - Endpoints News

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Endpoints News Endpoints.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.